Sri Sai Amrutha Pharma Private Limited

Sri Sai Amrutha Pharma Private Limited

Pharmaceutical company manufacturing and trading various drugs, formulations, and chemicals since 2008.
2008 | Hyderabad, Telangana (India) | Inactive

Last Updated:

April 22, 2024
HomeCompanySri Sai Amrutha Pharma Private Limited

Who are the key members and board of directors at Sri Sai Amrutha Pharma?

Board Members(4)

NameDesignationAppointment DateStatus
Sridhar Pulamamidi In Director 30-Sep-2011Current
Venkatesulu Adoni In Director 30-Sep-2011Current
Mahesh Adoni In Director 17-Apr-2008Current
Vasantha Adoni In Director 17-Apr-2008Current

Financial Performance and Corporate Structure Insights of Sri Sai Amrutha Pharma.

Sri Sai Amrutha Pharma Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 62.35% decrease. The company also saw a substantial fall in profitability, with a 10.82% decrease in profit. The company's net worth dipped by a decrease of 3.58%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-62.35%
Revenue from Operations
Total Assets
-12.43%
Profit or Loss
-10.82%
Net Worth
-3.58%
EBITDA
46.43%

Related Corporates (Common Directorship)

Charges (Loans)

Satisfied Charges

₹62.50 M

LenderAmountStatus

Bank Of Baroda

Creation Date: 19 Mar 2012
₹4.90 CrSatisfied

Bank Of Baroda

Creation Date: 19 Mar 2012
₹1.35 CrSatisfied

How Many Employees Work at Sri Sai Amrutha Pharma?

Unlock and access historical data on people associated with Sri Sai Amrutha Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Sri Sai Amrutha Pharma

Recent activity within the organization

  • Annual General Meeting

    Sri Sai Amrutha Pharma Private Limited last Annual general meeting of members was held on 25 Sep 2021 as per latest MCA records.

    25 Sep 2021

  • Balance Sheet

    Sri Sai Amrutha Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Hyderabad.

    31 Mar 2021

  • Charges

    A charge registered on 19 Mar 2012 via Charge ID 10347300 with Bank Of Baroda was fully satisfied on 04 May 2016.

    04 May 2016

  • Charges

    A charge registered on 19 Mar 2012 via Charge ID 10347301 with Bank Of Baroda was fully satisfied on 04 May 2016.

    04 May 2016

  • Charges

    A charge with Bank Of Baroda amounted to Rs. 49.00 M with Charge ID 10347300 was registered on 19 Mar 2012.

    19 Mar 2012

  • Charges

    A charge with Bank Of Baroda amounted to Rs. 13.50 M with Charge ID 10347301 was registered on 19 Mar 2012.

    19 Mar 2012

Frequently asked questions

  • Sri Sai Amrutha Pharma Private Limited was incorporated on 17 Apr 2008.

  • The authorized share capital of Sri Sai Amrutha Pharma Private Limited is ₹ 8.00 M and paid-up capital is ₹ 5.57 M.

  • Currently 4 directors are associated with Sri Sai Amrutha Pharma Private Limited.

    • Sridhar Pulamamidi
    • Venkatesulu Adoni
    • Mahesh Adoni
    • Vasantha Adoni
  • As per Ministry of Corporate Affairs (Mca), the registered address of Sri Sai Amrutha Pharma Private Limited is 8-3-224/11/3C(H-27)1Stfloor, Madhura Nagar, Hyderabad, Telangana, India, 500038.

  • The corporate identification number (CIN) of Sri Sai Amrutha Pharma Private Limited is U24233TG2008PTC058707 and the company number is 058707 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2021, the revenue trend for Sri Sai Amrutha Pharma Private Limited has fallen by -62.35%.

  • The financial reports for the fiscal year 2021 indicates that The net worth of Sri Sai Amrutha Pharma Private Limited has experienced an downturn of -3.58%.

  • The most recent Balance Sheet for Sri Sai Amrutha Pharma Private Limited was filed with the ROC on 31 Mar 2021.

Similar Companies Based on Drug Formulation & Development